APA (7th ed.) Citation

R, G., LM, D. L., L, I., N, U., V, E., C, C., . . . J, M. (2022). Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 9(20), e2201378. https://doi.org/10.1002/advs.202201378

Chicago Style (17th ed.) Citation

R, Groß, et al. "Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity Against SARS-CoV-2." Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 9, no. 20 (2022): e2201378. https://doi.org/10.1002/advs.202201378.

MLA (9th ed.) Citation

R, Groß, et al. "Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity Against SARS-CoV-2." Advanced Science (Weinheim, Baden-Wurttemberg, Germany), vol. 9, no. 20, 2022, p. e2201378, https://doi.org/10.1002/advs.202201378.